Bioxytran Guest Speaker on Perfusionists Continuing Education Program Discusses Acute Respiratory Distress Syndrome and Ways to Combat COVID-19
Learn MoreTo learn more and become a part of the fight against stroke, sign up for our company newsletter for updates and more.
to learn more and become a part of the fight against stroke, sign up for our company newsletter for updates and more
With hypoxia, seconds make the difference between life and death. We are committed to bridging those moments through the structure of co-polymers. Based on Dr. David Platt's groundbreaking research in carbohydrate chemistry, Bioxytran, Inc is developing treatments for stroke and many other medical situations related to hypoxic conditions.
In the United States, about 795,000 people suffer a stroke each year. Someone has a stroke every 40 seconds, and every 4 minutes someone dies from stroke. There are more than 140,000 deaths each year from stroke.
The key is BioXyTran's two workhorses: BXT-25 and BXT-252. Both drugs are designed to oxygenate ischemic (reduced blood flow) regions of the body and could provide sufferers valuable aid.